Bharat Serums and Vaccines on Thursday said it has attained a 26 per cent stake in AMP Energy C&I One to support green energy requirements for its manufacturing facility at Ambernath in Maharashtra. Aimed at driving a comprehensive sustainability blueprint for the future, this venture will help BSV avoid carbon dioxide emissions by as much as 65,60 tonnes of carbon dioxide equivalent (tCO2e) annually over its project life of 25 years.
"This solar project resonates our belief in building a greener environment, judiciously using natural resources and renewable sources of energy while creating measurable social impact," Bharat Serums and Vaccines (BSV) MD and CEO Sanjiv Navangul said.
The acquisition of the solar power firm is in line with the Mumbai-based firm endeavour to emerge as a carbon-neutral company by 2050, in addition to achieving water neutrality, product stewardship and an integrated management system.
This reaffirms our belief of enhancing our proportion of solar-based power consumption while complying with regulatory necessities of power consumption and contributing in our own humble way towards India's commitment of achieving 40 per cent of its installed electricity capacity from non-fossil energy sources by 2030," BSV Chief Financial Officer Chirag Mehta said.
The firm has eight specialised divisions to service domestic market requirements. It also has a significant presence across international markets.
.jpg "Oprichter Legal Network : Trusted Legal Expert Offering Comprehensive Client centric Legal Assistance")
.jpg "Technology in Cancer Care: A story of evolving paradigms")
.jpg "Bringing Shop Floor to Manufacturer's palm: Smart Factory Solutions for tomorrow")
